Top Markets
Coin of the day
Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd.

TARO
Rang in Aktien #7354
Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven... Taro Pharmaceutical Industries Ltd. operates as a scientifically-driven pharmaceutical enterprise, specializing in the development, manufacturing, and commercialization of both prescription and over-the-counter medications. Its market reach spans the United States, Canada, Israel, and various other international territories. The company also produces active pharmaceutical ingredients (APIs), primarily for integration into its own finished dosage form products. Its extensive product catalog addresses a broad spectrum of medical conditions and therapeutic areas, encompassing treatments for allergies, pain (analgesic), bacterial and fungal infections (antibacterial, antibiotic, antifungal), seizures (anticonvulsant), nausea (antiemetic), inflammation (anti-inflammatory), cancer (anti-cancer, topical anti-neoplastic), blood clot prevention (antiplatelet agent), fever reduction (antipyretic), cardiovascular issues, central nervous system disorders, hormonal regulation (corticosteroid, endocrine), cosmetic applications, coughs and colds, dermatological complaints, fluid management (diuretic), gastrointestinal problems, constipation (laxative), severe pain (narcotics), neuropathic pain, neuropsychiatric conditions, and sleep/anxiety management (sedative/hypnotic). These pharmaceutical goods are available in numerous formats, including capsules, creams, drops, emulsions, gels (and gel kits), granules, injectables, lotions, oils, ointments, pastes, powders (and powders for solution), rectal suppositories, shampoos, solutions (and solutions for infusion), sprays, suspensions, syrups, tablets, toothpastes and mouthwashes, topical foams, and topical solutions. Taro distributes and sells its products directly to a wide array of clients, such as pharmaceutical wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, other direct purchasers, and various healthcare institutions and private pharmacies. The company was established in 1950, with its main offices situated in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a wholly-owned subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
Aktienkurs
$42.98
Zuletzt synchronisiert: 2024-06-21
Marktkapitalisierung
$1.62B
Veränderung (1 Tag)
0.01%
Veränderung (1 Jahr)
0.00%
Land
IL
Handel Taro Pharmaceutical Industries Ltd. (TARO)

Kategorie

Gewinn für Taro Pharmaceutical Industries Ltd. (TARO)
Gewinn im Mar 2024 TTM: $82.67M
Laut den aktuellen Finanzberichten von Taro Pharmaceutical Industries Ltd. betragen die aktuellen Gewinne des Unternehmens $82.67M. Im Jahr 2023 erzielte das Unternehmen einen Gewinn von $38.21M, ein Rückgang im Vergleich zu dem Gewinn im Jahr 2022, der $77.86M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Taro Pharmaceutical Industries Ltd. von 1999 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
2026 (TTM) $82.67M 0.00%
2024 $82.67M 116.33%
2023 $38.21M -50.92%
2022 $77.86M -119.91%
2021 $-391.07M -231.35%
2020 $297.73M -16.57%
2019 $356.85M 22.06%
2018 $292.37M -47.87%
2017 $560.80M -11.94%
2016 $636.82M 9.48%
2015 $581.68M 31.04%
2014 $443.91M 32.17%
2013 $335.86M 39.40%
2012 $240.93M 219.63%
2010 $75.38M 60.06%
2009 $47.09M 6.88%
2008 $44.06M 8.67%
2007 $40.55M -149.57%
2006 $-81.81M -1,221.57%
2005 $7.29M -205.21%
2004 $-6.93M -109.50%
2003 $72.96M 37.75%
2002 $52.96M 74.37%
2001 $30.37M 141.72%
2000 $12.57M 79.24%
1999 $7.01M 0.00%
Gewinn ähnlicher Unternehmen oder Konkurrenten